Xarelto 2.5 mg film-coated tablets
Sponsors
Celgene Corp., Centre Hospitalier Regional Universitaire De Tours, Rigshospitalet, St. Antonius Ziekenhuis
Conditions
Chronic Thromboembolic Disease (CTED) without Pulmonary HypertensionChronic Thromboembolic Pulmonary Hypertension (CTEPH)Chronic hemodialysisNewly Diagnosed Multiple Myeloma (NDMM)Patients with
- Stable peripheral artery disease
and
- Asymptomaticatherosclerotic plaque/stenosis in the carotid artery;
asymptomatic regarding cerebral ischaemia including stroke and
transient ischaemic attack (TIA) or amaurosis fugax.
Phase 2
Phase 3
A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM) (EXCALIBER-Maintenance)
RecruitingCTIS2022-501515-14-00
Start: 2023-09-29Target: 464Updated: 2025-09-12
Stabilization of vulnerable atherosclerotic carotid plaques by Rivaroxaban as evaluated by 3D contrast enhanced ultrasound (CEUS)
Not yet recruitingCTIS2024-518539-13-00
Target: 62Updated: 2024-10-27